Theseus Pharmaceuticals Inc logo

Theseus Pharmaceuticals Inc

$ 5.80 -0.3 (-4.92%) 08:08 PM EST
P/E:
At Loss
P/B:
0.96
Market Cap:
$ 224.54M
Enterprise V:
$ 15.57M
Volume:
65.68K
Avg Vol (2M):
39.33K
Volume:
65.68K
Market Cap $:
224.54M
PE Ratio:
At Loss
Avg Vol (2-Month):
39.33K
Enterprise Value $:
15.57M
PB Ratio:
0.96
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Theseus Pharmaceuticals Inc is a biopharmaceutical company focused on improving the lives of cancer patients through the discovery, development and commercialization of transformative targeted therapies. The company's development programs are designed to address drug resistance mutations in key driver oncogenes, which are mutated genes that cause cancer.
Name Current Vs Industry Vs History
Cash-To-Debt 53.32
Equity-to-Asset 0.96
Debt-to-Equity 0.02
Debt-to-EBITDA -0.11
Interest Coverage N/A
N/A
N/A
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 29.88
9-Day RSI 30.92
14-Day RSI 34.28
6-1 Month Momentum % -40.85

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 43.66
Quick Ratio 43.66
Cash Ratio 43.14

Dividend & Buy Back

Name Current Vs Industry Vs History
Name Current Vs Industry Vs History
ROE % -30.83
ROA % -20.38
ROIC % -470.67
ROC (Joel Greenblatt) % -1191.13
ROCE % -21.2

Financials (Next Earnings Date:2022-11-15 Est.)

THRX's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:THRX

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -1.016
Beta 0
Volatility % 0
14-Day RSI 34.28
14-Day ATR ($) 0.7277
20-Day SMA ($) 6.707
12-1 Month Momentum % 0
52-Week Range ($) 4.857 - 24.54
Shares Outstanding (Mil) 38.71

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Theseus Pharmaceuticals Inc Filings

Document Form Filing Date
No Filing Data

Theseus Pharmaceuticals Inc Analysis

Share your research

Headlines

See More
No news.